TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.

J O'Shaughnessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.